Press Release: CDEX Develops First Meth Scanner

[hausdok]

TUCSON, AZ--(MARKET WIRE)—July 17, 2008

CDEX Inc. (OTC BB:CEXI) announces its first sales and deliveries of ID2 Meth Scannersâ„¢ for methamphetamine detection to U.S. clients in the Law Enforcement and Home Inspection Markets, and to U.S. and international distributors.

The ID2 Meth Scannerâ„¢ is a hand-held, battery operated device that detects trace amounts of methamphetamine (low nanogram range) on virtually any surface while in the continuous scan mode. It employs the same CDEX patented Enhanced Photoemission Spectroscopy technology used in the ValiMedâ„¢ System, currently saving lives in hospitals today.

"We are excited about the commercialization of the ID2 Meth Scanner following two years of extensive R&D, beta testing and market research by the CDEX Team,â€